Based on observations in the USA, Spain, Italy, France, and the UK, and from postmortem of lung involvement in COVID 19, all revealed pulmonary thrombosis, which is not typical ARDS. More alarming, was that patient hypoxemia was not responding to PEEP but high oxygen flow.
Unlocking Drug Delivery to the Brain: Phase 3 Pivotal Trial Uses Ultrasound to Break Through the Blood-Brain Barrier | By: Michael Canney, Ph.D., is Chief Scientific Officer at Carthera
Imagine what modern medicine would be like without the ability to effectively and consistently administer drugs intravenously. That’s a good way to frame the huge delivery limitation that plagues neuroscience: Despite all the advances in drug discovery over the past decades, the biggest roadblock to treating brain cancers and other neurological diseases and disorders remains the brain’s own protective shield, the blood-brain barrier. Read on.